Evidence map›Paper›PMID 37802617›Full record

ArticleBMJ open2023

Classification of post COVID-19 condition symptoms: a longitudinal study in the Belgian population.

Sarah Nayani, Diego Castanares-Zapatero, Robby De Pauw, Dieter Van Cauteren, Stefaan Demarest, Sabine Drieskens, Laura Cornelissen, Brecht Devleesschauwer, Karin De Ridder, Rana Charafeddine and 1 more

Open access · goldAbstract read
In one paragraph

Article in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 2 pooled it
1.9field-weighted citation impact, top 14% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 2 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 3 institutions in 1 country.

Sarah NayaniEpidemiology and Public Health, Sciensano, Brussels, Belgium sarah.nayani@sciensano.be.ORCID 0000-0002-4842-9645
Diego Castanares-ZapateroHealth Services Research, Belgian Health Care Knowledge Centre, Brussels, Belgium.
Robby De PauwEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Dieter Van CauterenEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Stefaan DemarestEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Sabine DrieskensEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Laura CornelissenEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Brecht DevleesschauwerEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Karin De RidderEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Rana CharafeddineEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Pierre SmithEpidemiology and Public Health, Sciensano, Brussels, Belgium.
Sciensano (Belgium) · BEGhent University Hospital · BEBelgian Health Care Knowledge Centre (KCE) · BE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectivesSince the onset of the COVID-19 pandemic, most research has focused on its acute pathophysiology, yet some people tend to experience persisting symptoms beyond the acute phase of infection, referred to as post COVID-19 condition (PCC). However, evidence on PCC is still scarce. This study aimed to assess the distribution, classification of symptoms and associated factors of PCC in adults.

designLongitudinal online cohort study.

settingNational study in Belgium.

participantsParticipants were Belgian adults with a recent SARS-CoV-2 infection and were recruited when called up for contact tracing. A total of 3039 participants were included and completed an online questionnaire at the time of their infection and again 3 months later. OUTCOME MEASURES: The baseline questionnaire assessed the initial health status of the participants and their status during the acute phase of the infection. The follow-up questionnaire assessed their PCC status 3 months after infection. A latent class analysis (LCA) was performed to assess whether there are different classes of individuals with a similar set of self-reported PCC symptoms.

resultsHalf of the participants reported PCC 3 months after infection (47%). The most frequent symptoms were fatigue (21%), headache (11%) and memory problems (10%). The LCA highlighted three different classes of PCC symptoms with different risk factors: (1) a combination of loss of smell and taste, (2) a combination of neurological symptoms and (3) other heterogeneous symptoms.

conclusionsWith the increasing number of people who underwent COVID-19, PCC has become an important but complex public health problem due to the heterogeneity of its symptoms. The classification of symptoms performed in this study can help give insight into different aetiologies of PCC and better plan care according to the symptoms and needs of those affected.

Indexed as

COVID-19PandemicsAdultBelgiumCohort StudiesHumansLongitudinal StudiesSARS-CoV-2Self ReportCOVID-19EPIDEMIOLOGYPUBLIC HEALTH

Identifiers

PMID37802617
PMCPMC10565235
OpenAlexW4387440157

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.